Effectiveness and Feasibility of Patient Controlled Analgesia in the ED
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
Bronx, New York, United States, 10461
- Jacobi Medical Center
-
Bronx, New York, United States, 10467
- Montefiore Medical Center - Moses Division
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18 to 65
- Patient deemed by the ED attending physician to require IV opioid analgesia for pain and for whom the ED Attending Physician would consider using PCA
Exclusion Criteria:
- Patients requiring initial resuscitation that would preclude the use of PCA
- Long-term use of prescription or non-prescription opioids now or within the past year
- Recent opioid use within the past 24 hours
- Chronic pain syndromes
- Clinician suspicion of current or past opioid dependence/abuse
- Altered mental status/Clinical suspicion of intoxication
- Patients expected to require conscious sedation while in the ED
- Pregnancy or breast-feeding
- History of chronic obstructive pulmonary disease, history of sleep apnea syndrome, baseline oxygen saturation (room air) < 97%
- Systolic blood pressure < 100 mm Hg
- Use of sedative medications e.g. benzodiazepines, monoamine oxidase inhibitors, phenothiazines, or tricyclic antidepressants.
- History of renal insufficiency/renal failure
- Prior allergic reaction to morphine
- Inability to provide informed consent or inability to understand or operate PCA device
- Previous entry of patient into study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Patient Controlled Analgesia
PCA (loading dose 0.1 mg/kg morphine and demand dose of 1 mg morphine available every 6 minutes)
|
Loading dose 0.1 mg/kg morphine and demand dose of 1 mg morphine available every 6 minutes
|
|
Active Comparator: Usual Care
Usual opioid analgesia determined by the provider
|
Usual opioid analgesia determined by the provider
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of Change in Pain Intensity Per Hour
Time Frame: 1.5 hours
|
Rate of Change in Numerical Rating Scale (NRS) of Pain per hour where 0 indicates "no pain", 10 indicates "worst possible pain" between 30 minutes and 120 minutes post-baseline i.e.
NRS at 30 minutes minus NRS at 120 minutes post-baseline.
|
1.5 hours
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants With One or More Adverse Events
Time Frame: 2 hours
|
Number of participants with one or more adverse events defined by: oxygen saturation measured by pulse oximetry < 92% for one minute or more, respiratory rate <10 breaths/min counted for 60 seconds, or systolic blood pressure < 90 mm Hg.
|
2 hours
|
|
Patient Satisfaction With Pain Management
Time Frame: 2 hours
|
Self report of satisfaction with treatment at120 minutes after baseline
|
2 hours
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Nurse Preference for PCA or Conventional Administration of IV Opioids
Time Frame: 2 hours
|
Single question about preference for PCA versus preference for conventional administration of IV opioids.
|
2 hours
|
|
Physician Preference for PCA or Usual Care
Time Frame: 2 hours
|
Single question about physician preference for PCA or conventional administration of IV opioids
|
2 hours
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Polly Bijur, PhD, Albert Einstein College of Medicine
- Principal Investigator: Adrienne Birnbaum, MD, Jacobi Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- 2012-485
- R01NR013980 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.